Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 11
Submit an article Journal homepage
3,095
Views
59
CrossRef citations to date
0
Altmetric
REVIEW

Trial watch: Dendritic cell-based anticancer therapy

Norma BloyGustave Roussy Cancer Campus; Villejuif, France;INSERM, U1138; ParisFrance;Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; ParisFrance;Université Paris-Sud/Paris XI; Orsay, France
,
Jonathan PolGustave Roussy Cancer Campus; Villejuif, France;INSERM, U1138; ParisFrance;Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; ParisFrance
,
Fernando ArandaGustave Roussy Cancer Campus; Villejuif, France;INSERM, U1138; ParisFrance;Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; ParisFrance
,
Alexander EggermontGustave Roussy Cancer Campus; Villejuif, France
,
Isabelle CremerINSERM, U1138; ParisFrance;Equipe 13; Centre de Recherche des Cordeliers; ParisFrance;Université Pierre et Marie Curie/Paris VI; ParisFrance
,
Wolf Hervé FridmanINSERM, U1138; ParisFrance;Equipe 13; Centre de Recherche des Cordeliers; ParisFrance;Université Pierre et Marie Curie/Paris VI; ParisFrance
,
Jitka FučíkováDepartment of Immunology; 2 Medical School Charles University and University Hospital Motol; Prague, Czech Republic;Sotio a.s.; Prague, Czech Republic
,
Jérôme GalonINSERM, U1138; ParisFrance;Université Pierre et Marie Curie/Paris VI; ParisFrance;Laboratory of Integrative Cancer Immunology; Centre de Recherche des Cordeliers; ParisFrance;Université Paris Descartes/Paris V; Sorbonne Paris Cité; ParisFrance
,
Eric TartourUniversité Paris Descartes/Paris V; Sorbonne Paris Cité; ParisFrance;INSERM, U970; ParisFrance;Pôle de Biologie; Hôpital Européen Georges Pompidou, AP-HP; ParisFrance
,
Radek SpisekDepartment of Immunology; 2 Medical School Charles University and University Hospital Motol; Prague, Czech Republic;Sotio a.s.; Prague, Czech Republic
,
Madhav V. DhodapkarDepartment of Medicine; Immunobiology and Yale Cancer Center; Yale University; New Haven, CTUSA
,
Laurence ZitvogelGustave Roussy Cancer Campus; Villejuif, France;INSERM, U1015, CICBT507; Villejuif, France
,
Guido KroemerINSERM, U1138; ParisFrance;Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; ParisFrance;Université Paris Descartes/Paris V; Sorbonne Paris Cité; ParisFrance;Pôle de Biologie; Hôpital Européen Georges Pompidou, AP-HP; ParisFrance;Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif, FranceCorrespondence[email protected] [email protected]
&
Lorenzo GalluzziGustave Roussy Cancer Campus; Villejuif, France;INSERM, U1138; ParisFrance;Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; ParisFrance;Université Paris Descartes/Paris V; Sorbonne Paris Cité; ParisFranceCorrespondence[email protected] [email protected]
 show all
Article: e963424 | Received 04 Sep 2014, Accepted 05 Sep 2014, Published online: 29 Oct 2014

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, Yuta Mishima, Noriko Watanabe, Takashi Yamada, Satoru Senju, Shin Kaneko, Alimjan Idiris, Tetsuya Nakatsura, Hideki Ohdan & Yasushi Uemura. (2020) Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response. OncoImmunology 9:1.
Read now
Jonathan G. Pol, Sergio A. Acuna, Beta Yadollahi, Nan Tang, Kyle B. Stephenson, Matthew J. Atherton, David Hanwell, Alexander El-Warrak, Alyssa Goldstein, Badru Moloo, Patricia V. Turner, Roberto Lopez, Sandra LaFrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G. Martin, Julia Pomoransky, Caroline J. Breitbach, Jonathan L. Bramson, John C. Bell, Yonghong Wan, David F. Stojdl, Brian D. Lichty & J. Andrea McCart. (2019) Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials. OncoImmunology 8:1.
Read now
Grammatiki Fotaki, Chuan Jin, Iliana Kyriaki Kerzeli, Mohanraj Ramachandran, Minttu-Maria Martikainen, Alex Karlsson-Parra, Di Yu & Magnus Essand. (2018) Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models. OncoImmunology 7:3.
Read now
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now
Srinivas Ramishetti, Dalit Landesman-Milo & Dan Peer. (2016) Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles. Journal of Drug Targeting 24:9, pages 780-786.
Read now
Maureen L. Drakes & Patrick J. Stiff. (2016) Understanding dendritic cell immunotherapy in ovarian cancer. Expert Review of Anticancer Therapy 16:6, pages 643-652.
Read now
Kristina Iribarren, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Špíšek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. OncoImmunology 5:3.
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Lorenzo Galluzzi, Alexander Eggermont & Guido Kroemer. (2016) Doubling the blockade for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now

Articles from other publishers (46)

Sajad Najafi & Keywan Mortezaee. (2023) Advances in dendritic cell vaccination therapy of cancer. Biomedicine & Pharmacotherapy 164, pages 114954.
Crossref
Yi-Yen Lee, Shao-Ciao Luo, Chung-Hsin Lee, Chien-Lun Tang, Chiung-Chyi Shen, Wen-Yu Cheng, Yi-Chin Yang, Meng-Yin Yang & Chun-Ming Yen. (2023) Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing. BMC Immunology 24:1.
Crossref
Heng Dong, Qiang Li, Yu Zhang, Meng Ding, Zhaogang Teng & Yongbin Mou. (2023) Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy. Advanced Science 10:18.
Crossref
Marek Jedlička, Tereza Feglarová, Lucie Janstová, Marcela Hortová-Kohoutková & Jan Frič. (2022) Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies. Frontiers in Immunology 13.
Crossref
Takuya Tada, Thomas D. Norton, Rebecca Leibowitz & Nathaniel R. Landau. (2022) Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection. JCI Insight 7:18.
Crossref
Zhanran Zhao, Guangzhi Zhang, Yuefang Sun & Astar Winoto. (2020) Necroptotic‐susceptible dendritic cells exhibit enhanced antitumor activities in mice. Immunity, Inflammation and Disease 8:3, pages 468-479.
Crossref
Sandra Santos-Sierra. (2020) Developments in anticancer vaccination: budding new adjuvants. Biological Chemistry 401:4, pages 435-446.
Crossref
Caroline Boudousquié, Valérie Boand, Emilie Lingre, Laeticia Dutoit, Klara Balint, Maxime Danilo, Alexandre Harari, Philippe O. Gannon & Lana E. Kandalaft. (2020) Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines 8:1, pages 25.
Crossref
Rui Zhang, Fengjiao Yuan, Yang Shu, Yaomei Tian, Bailing Zhou, Linglu Yi, Xueyan Zhang, Zhenyu Ding, Heng Xu & Li Yang. (2019) Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models. Cancer Immunology, Immunotherapy 69:1, pages 135-145.
Crossref
Qixia Xu, Qilai Long, Dexiang Zhu, Da Fu, Boyi Zhang, Liu Han, Min Qian, Jianming Guo, Jianmin Xu, Liu Cao, Y. Eugene Chin, Jean‐Philippe Coppé, Eric W.‐F. Lam, Judith Campisi & Yu Sun. (2019) Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression. Aging Cell 18:6.
Crossref
Jinju Yang, Hongwei Zhang, Ziwei Zhu, Yadan Gao, Benqiong Xiang & Qun Wei. (2019) The immunostimulatory effects and pro‐apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll‐like receptor 4. Cancer Medicine 8:9, pages 4441-4453.
Crossref
Beatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquie, Philippe O. Gannon & Lana E. Kandalaft. (2019) Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results. Frontiers in Immunology 10.
Crossref
CHARLOTTE DE Wolf, MARJA VAN DE BOVENKAMP & MARCEL HOEFNAGEL. (2018) Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy. Cytotherapy 20:11, pages 1289-1308.
Crossref
Shurong Ren, Qiubo Wang, Yanli Zhang, Yancheng Song, Xue Dong, Wendi Zhang, Xianfei Qin, Mingyue Liu & Ting Yu. (2018) Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma. International Immunopharmacology 64, pages 69-77.
Crossref
Emile J. Clappaert, Aleksandar Murgaski, Helena Van Damme, Mate Kiss & Damya Laoui. (2018) Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy. Frontiers in Immunology 9.
Crossref
Dag Heiro Yi, Nadine Stetter, Kjerstin Jakobsen, Roland Jonsson & Silke Appel. (2018) 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy. Cancer Immunology, Immunotherapy 67:10, pages 1611-1620.
Crossref
Yi-Jun Wang, Rochelle Fletcher, Jian Yu & Lin Zhang. (2018) Immunogenic effects of chemotherapy-induced tumor cell death. Genes & Diseases 5:3, pages 194-203.
Crossref
Jeremy M. Grenier, Stephen T. Yeung & Kamal M. Khanna. (2018) Combination Immunotherapy: Taking Cancer Vaccines to the Next Level. Frontiers in Immunology 9.
Crossref
Cuili Huang, Lidan Zhang, Fang Ling, Sijian Wen, Yanyan Luo, Hui Liu, Jingping Liu, Wenjun Zheng, Ming Liang, Jian Sun & You‑Kun Lin. (2018) Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in�vivo study. Experimental and Therapeutic Medicine.
Crossref
Kai Shi, Matthew Haynes & Leaf Huang. (2017) Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy. Frontiers of Chemical Science and Engineering 11:4, pages 676-684.
Crossref
Julie Frentzel, Domenico Sorrentino & Sylvie Giuriato. (2017) Targeting Autophagy in ALK-Associated Cancers. Cancers 9:12, pages 161.
Crossref
Xinbing Sui, Liming Lei, Liuxi Chen, Tian Xie & Xue Li. (2017) Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget 8:54, pages 93279-93294.
Crossref
Tanja Lövgren, Dhifaf Sarhan, Iva Truxová, Bhavesh Choudhary, Roeltje Maas, Jeroen Melief, Maria Nyström, Ulrika Edbäck, Renee Vermeij, Gina Scurti, Michael Nishimura, Giuseppe Masucci, Alex Karlsson-Parra, Andreas Lundqvist, Lars Adamson & Rolf Kiessling. (2017) Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. Cancer Immunology, Immunotherapy 66:10, pages 1333-1344.
Crossref
Katherine Bonter, Zackariah Breckenridge, Silvy Lachance, Jean-Sébastien Delisle & Tania Bubela. (2017) Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials. Regenerative Medicine 12:6, pages 623-636.
Crossref
Mohanraj Ramachandran, Anna Dimberg & Magnus Essand. (2017) The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells. Seminars in Cancer Biology 45, pages 23-35.
Crossref
Abhishek D. Garg, Pierre G. Coulie, Benoit J. Van den Eynde & Patrizia Agostinis. (2017) Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape. Trends in Immunology 38:8, pages 577-593.
Crossref
Antonin Levy, Giulia Nigro, Philippe J. Sansonetti & Eric Deutsch. (2017) Candidate immune biomarkers for radioimmunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 58-68.
Crossref
Kieng Bao Vang, Ingrid Safina, Emilie Darrigues, Dmitry Nedosekin, Zeid A. Nima, Waqar Majeed, Fumiya Watanabe, Ganesh Kannarpady, Rajshekhar A. Kore, Daniel Casciano, Vladimir P. Zharov, Robert J. Griffin, Ruud P. M. Dings & Alexandru S. Biris. (2017) Modifying Dendritic Cell Activation with Plasmonic Nano Vectors. Scientific Reports 7:1.
Crossref
Kerstin F. Gerer, Michael Erdmann, Sine R. Hadrup, Rikke Lyngaa, Lena-Marie Martin, Reinhard E. Voll, Beatrice Schuler-Thurner, Gerold Schuler, Niels Schaft, Stefanie Hoyer & Jan Dörrie. (2017) Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination. Therapeutic Advances in Medical Oncology 9:7, pages 451-464.
Crossref
Jiri Keirsse, Helena Van Damme, Jo A Van Ginderachter & Damya Laoui. (2017) Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies. Journal of Leukocyte Biology 102:2, pages 317-324.
Crossref
Rui Li, Fang Fang, Ming Jiang, Chenguang Wang, Jiajia Ma, Wenyao Kang, Qiuyan Zhang, Yuhui Miao, Dong Wang, Yugang Guo, Linnan Zhang, Yang Guo, Hui Zhao, De Yang, Zhigang Tian & Weihua Xiao. (2017) STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer. Scientific Reports 7:1.
Crossref
Paula Mosińska, Agata Gabryelska, Malwina Zasada & Jakub Fichna. (2017) Dual Functional Capability of Dendritic Cells – Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy. Frontiers in Pharmacology 8.
Crossref
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2016) Immunogenic cell death in cancer and infectious disease. Nature Reviews Immunology 17:2, pages 97-111.
Crossref
Anne Montfort, Oliver Pearce, Eleni Maniati, Benjamin G. Vincent, Lisa Bixby, Steffen Böhm, Thomas Dowe, Edmund H. Wilkes, Probir Chakravarty, Richard Thompson, Joanne Topping, Pedro R. Cutillas, Michelle Lockley, Jonathan S. Serody, Melania Capasso & Frances R. Balkwill. (2017) A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases. Clinical Cancer Research 23:1, pages 250-262.
Crossref
Luisa Circelli, Annacarmen Petrizzo, Maria Tagliamonte, Regina Heidenreich, Maria Lina Tornesello, Franco M. Buonaguro & Luigi Buonaguro. (2016) Immunological effects of a novel RNA-based adjuvant in liver cancer patients. Cancer Immunology, Immunotherapy 66:1, pages 103-112.
Crossref
Kerstin F. Gerer, Stefanie Hoyer, Jan Dörrie & Niels Schaft. 2017. RNA Vaccines. RNA Vaccines 165 178 .
Damya Laoui, Jiri Keirsse, Yannick Morias, Eva Van Overmeire, Xenia Geeraerts, Yvon Elkrim, Mate Kiss, Evangelia Bolli, Qods Lahmar, Dorine Sichien, Jens Serneels, Charlotte L. Scott, Louis Boon, Patrick De Baetselier, Massimiliano Mazzone, Martin Guilliams & Jo A. Van Ginderachter. (2016) The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nature Communications 7:1.
Crossref
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira & Haruo Sugiyama. (2016) Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. Immunotherapy 8:11, pages 1309-1320.
Crossref
Andrea Tuettenberg, Kerstin Steinbrink & Detlef Schuppan. (2016) Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy. Nanomedicine 11:20, pages 2735-2751.
Crossref
Camilla Engblom, Christina Pfirschke & Mikael J. Pittet. (2016) The role of myeloid cells in cancer therapies. Nature Reviews Cancer 16:7, pages 447-462.
Crossref
Shigeo Koido. (2016) Dendritic-Tumor Fusion Cell-Based Cancer Vaccines. International Journal of Molecular Sciences 17:6, pages 828.
Crossref
Jian Qiao, Zhida Liu & Yang-Xin Fu. (2016) Adapting conventional cancer treatment for immunotherapy. Journal of Molecular Medicine 94:5, pages 489-495.
Crossref
Rudolf Käfer, Svetlana Usanova, Evelyn Montermann, Carmen Loquai, Angelika B. Reske-Kunz & Matthias Bros. (2016) Inhibitors of β-catenin affect the immuno-phenotype and functions of dendritic cells in an inhibitor-specific manner. International Immunopharmacology 32, pages 118-124.
Crossref
R Oostvogels, H M Lokhorst & T Mutis. (2015) Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives. Bone Marrow Transplantation 51:2, pages 163-171.
Crossref
Ilka Knippertz, Andrea Deinzer, Jan Dörrie, Niels Schaft, Dirk M. Nettelbeck & Alexander Steinkasserer. (2016) Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation. Journal of Immunology Research 2016, pages 1-17.
Crossref
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2015) Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell 28:6, pages 690-714.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.